113 related articles for article (PubMed ID: 25891300)
1. Phosphatidylinositol 4-kinase III beta is the target of oxoglaucine and pachypodol (Ro 09-0179) for their anti-poliovirus activities, and is located at upstream of the target step of brefeldin A.
Arita M; Philipov S; Galabov AS
Microbiol Immunol; 2015 Jun; 59(6):338-47. PubMed ID: 25891300
[TBL] [Abstract][Full Text] [Related]
2. Phosphatidylinositol-4 kinase III beta and oxysterol-binding protein accumulate unesterified cholesterol on poliovirus-induced membrane structure.
Arita M
Microbiol Immunol; 2014 Apr; 58(4):239-56. PubMed ID: 24527995
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of Poliovirus Resistance to Host Phosphatidylinositol-4 Kinase III β Inhibitor.
Arita M
ACS Infect Dis; 2016 Feb; 2(2):140-8. PubMed ID: 27624965
[TBL] [Abstract][Full Text] [Related]
4. Poliovirus Evolution toward Independence from the Phosphatidylinositol-4 Kinase III β/Oxysterol-Binding Protein Family I Pathway.
Arita M; Bigay J
ACS Infect Dis; 2019 Jun; 5(6):962-973. PubMed ID: 30919621
[TBL] [Abstract][Full Text] [Related]
5. Modulation of proteolytic polyprotein processing by coxsackievirus mutants resistant to inhibitors targeting phosphatidylinositol-4-kinase IIIβ or oxysterol binding protein.
Lyoo H; Dorobantu CM; van der Schaar HM; van Kuppeveld FJM
Antiviral Res; 2017 Nov; 147():86-90. PubMed ID: 29024767
[TBL] [Abstract][Full Text] [Related]
6. Involvement of membrane traffic in the replication of poliovirus genomes: effects of brefeldin A.
Irurzun A; Perez L; Carrasco L
Virology; 1992 Nov; 191(1):166-75. PubMed ID: 1329315
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidylinositol 4-kinase III beta is a target of enviroxime-like compounds for antipoliovirus activity.
Arita M; Kojima H; Nagano T; Okabe T; Wakita T; Shimizu H
J Virol; 2011 Mar; 85(5):2364-72. PubMed ID: 21177810
[TBL] [Abstract][Full Text] [Related]
8. Mutations in Encephalomyocarditis Virus 3A Protein Uncouple the Dependency of Genome Replication on Host Factors Phosphatidylinositol 4-Kinase IIIα and Oxysterol-Binding Protein.
Dorobantu CM; Albulescu L; Lyoo H; van Kampen M; De Francesco R; Lohmann V; Harak C; van der Schaar HM; Strating JR; Gorbalenya AE; van Kuppeveld FJ
mSphere; 2016; 1(3):. PubMed ID: 27303747
[TBL] [Abstract][Full Text] [Related]
9. Uncovering oxysterol-binding protein (OSBP) as a target of the anti-enteroviral compound TTP-8307.
Albulescu L; Bigay J; Biswas B; Weber-Boyvat M; Dorobantu CM; Delang L; van der Schaar HM; Jung YS; Neyts J; Olkkonen VM; van Kuppeveld FJM; Strating JRPM
Antiviral Res; 2017 Apr; 140():37-44. PubMed ID: 28088354
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the Role of Protein Kinase D in Human Rhinovirus Replication.
Guedán A; Swieboda D; Charles M; Toussaint M; Johnston SL; Asfor A; Panjwani A; Tuthill TJ; Danahay H; Raynham T; Mousnier A; Solari R
J Virol; 2017 May; 91(9):. PubMed ID: 28228588
[TBL] [Abstract][Full Text] [Related]
11. Model of OSBP-Mediated Cholesterol Supply to Aichi Virus RNA Replication Sites Involving Protein-Protein Interactions among Viral Proteins, ACBD3, OSBP, VAP-A/B, and SAC1.
Ishikawa-Sasaki K; Nagashima S; Taniguchi K; Sasaki J
J Virol; 2018 Apr; 92(8):. PubMed ID: 29367253
[TBL] [Abstract][Full Text] [Related]
12. A complex comprising phosphatidylinositol 4-kinase IIIβ, ACBD3, and Aichi virus proteins enhances phosphatidylinositol 4-phosphate synthesis and is critical for formation of the viral replication complex.
Ishikawa-Sasaki K; Sasaki J; Taniguchi K
J Virol; 2014 Jun; 88(12):6586-98. PubMed ID: 24672044
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of poliovirus RNA synthesis by brefeldin A.
Maynell LA; Kirkegaard K; Klymkowsky MW
J Virol; 1992 Apr; 66(4):1985-94. PubMed ID: 1312615
[TBL] [Abstract][Full Text] [Related]
14. Oxysterol-binding protein family I is the target of minor enviroxime-like compounds.
Arita M; Kojima H; Nagano T; Okabe T; Wakita T; Shimizu H
J Virol; 2013 Apr; 87(8):4252-60. PubMed ID: 23365445
[TBL] [Abstract][Full Text] [Related]
15. Essential domains of phosphatidylinositol-4 kinase III β required for enterovirus replication.
Arita M
Microbiol Immunol; 2019 Jul; 63(7):285-288. PubMed ID: 31166044
[TBL] [Abstract][Full Text] [Related]
16. High-Order Epistasis and Functional Coupling of Infection Steps Drive Virus Evolution toward Independence from a Host Pathway.
Arita M
Microbiol Spectr; 2021 Oct; 9(2):e0080021. PubMed ID: 34468191
[TBL] [Abstract][Full Text] [Related]
17. [Exploration for anti-enterovirus compounds and analysis on the mechanism of its inhibitory effect on virus infection].
Arita M
Uirusu; 2013; 63(1):93-102. PubMed ID: 24769585
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Anti-Poliovirus Compounds Isolated from Edible Plants.
Arita M; Fuchino H
Viruses; 2023 Mar; 15(4):. PubMed ID: 37112883
[TBL] [Abstract][Full Text] [Related]
19. The poliovirus replication machinery can escape inhibition by an antiviral drug that targets a host cell protein.
Crotty S; Saleh MC; Gitlin L; Beske O; Andino R
J Virol; 2004 Apr; 78(7):3378-86. PubMed ID: 15016860
[TBL] [Abstract][Full Text] [Related]
20. Allosteric Regulation of Phosphatidylinositol 4-Kinase III Beta by an Antipicornavirus Compound MDL-860.
Arita M; Dobrikov G; Pürstinger G; Galabov AS
ACS Infect Dis; 2017 Aug; 3(8):585-594. PubMed ID: 28605587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
